查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713456

2025年产前检测与新生儿筛检全球市场报告

Prenatal Testing & Newborn Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年产前检测和新生儿筛检市场将快速成长。到 2029 年，这一数字将成长至 110.8 亿美元，年复合成长率（CAGR）为 12.2%。预测期内的成长可归因于遗传咨询、技术进步、就地检验、远端医疗和远端监控。预测期内的主要趋势包括非侵入性产前检测（NIPT）、胚胎着床前基因检测（PGT）、远端医疗咨询、母体血液检测、血红蛋白疾病和镰状细胞筛检。

产前检测和新生儿筛检市场的成长很大程度上是由婴幼儿遗传疾病的高发性所推动的。世界卫生组织已确定的遗传疾病有地中海贫血、镰状细胞性贫血、血友病、囊肿纤维化、戴-萨克斯病、X染色体脆折症候群和亨丁顿氏病。镰状细胞性贫血症尤其普遍，影响非洲、美国、古巴、中美洲、沙乌地阿拉伯和印度血统的人。例如，2023年2月，美国研究机构雷迪儿童基因组医学研究所报告称，雷迪儿童医院的一项研究发现，41%的婴儿死亡是由于单基因座（孟德尔）遗传疾病造成的。婴幼儿遗传病患病率的不断上升推动了产前检测和新生儿筛检的需求。

随着出生率的上升，产前检测和新生儿筛检市场有望成长。产前检查可评估胎儿出生前的健康状况，而新生儿筛检可在出生后不久检测出某些医疗状况，以便在需要时进行早期疗育。例如，美国疾病管制与预防中心（CDC）2024年4月发布的报告显示，2023年剖腹产率连续第四年上升，达32.4%。此外，低风险剖腹产率上升至26.6%。因此，出生率上升是产前检测和新生儿筛检市场的主要驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球产前检测与新生儿筛检PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球产前检测与新生儿筛检市场：成长率分析
  • 全球产前检测与新生儿筛检市场表现：规模与成长，2019-2024
  • 全球产前检测与新生儿筛检市场预测：规模与成长，2024-2029 年，2034 年
  • 全球产前检测与新生儿筛检总目标市场（TAM）

第六章市场区隔

  • 全球产前检测和新生儿筛检市场（按诊断类型、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 非侵入性
  • 侵入性
  • 全球产前检测及新生儿筛检市场（依技术、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 筛检技术
  • 诊断技术
  • 全球产前检测和新生儿筛检市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 全球产前检测和新生儿筛检市场非侵入性细分市场，按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液检测（游离细胞DNA检测）
  • 超音波
  • 母体血清筛检
  • 全球产前检测和新生儿筛检市场，侵入性细分，按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 羊膜穿刺术
  • 绒毛膜绒毛采样（CVS）
  • 脐带穿刺

第七章 区域和国家分析

  • 全球产前检测与新生儿筛检市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球产前检测与新生儿筛检市场：按国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 产前检测与新生儿筛检市场：竞争格局
  • 产前检测与新生儿筛检市场：公司简介
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings（LabCorp）Overview, Products and Services, Strategy and Financial Analysis
    • Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Centogene AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Cradle Genomics Inc.
  • Roche Diagnostics International AG
  • Quest Diagnostics Incorporated
  • Baebies Inc.
  • Progenity Inc.
  • Ravgen Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Eurofins Scientific
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories Inc.
  • General Electric Company
  • Siemens Healthineers AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年产前检测与新生儿筛检市场：提供新机会的国家
  • 2029年产前检测与新生儿筛检市场：细分领域带来新机会
  • 2029年产前检测与新生儿筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r32735

Prenatal testing and newborn screening are medical practices designed to evaluate the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing encompasses a range of assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, enabling early intervention and treatment to enhance health outcomes for infants.

The primary diagnostic categories within prenatal testing and newborn screening encompass non-invasive and invasive methods. Invasive diagnostic testing involves procedures that penetrate the skin or body, including techniques such as blood testing, biopsies, and colonoscopies. These diagnostic methods leverage various technologies, including screening and diagnostic technology, and are applied across a range of sectors, including hospitals and diagnostic centers.

The prenatal testing & newborn screening market research report is one of a series of new reports from The Business Research Company that provides prenatal testing & newborn screening market statistics, including prenatal testing & newborn screening industry global market size, regional shares, competitors with prenatal testing & newborn screening market share, detailed prenatal testing & newborn screening market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal testing and newborn screening tests industry. This prenatal testing and newborn screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $6.24 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to advancements in genetic testing, increased maternal age, awareness and education, healthcare policy and regulations.

The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $11.08 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to genetic counseling, technological advancements, point-of-care testing, telehealth and remote monitoring. Major trends in the forecast period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies and sickle cell screening.

The growth of the prenatal testing and newborn screening market is significantly driven by the high prevalence of genetic diseases in infants. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Among these, Sickle Cell Anemia, which predominantly affects individuals with African, American, Cuban, Central American, Saudi Arabian, and Indian ancestry, is particularly widespread. For instance, in February 2023, the Rady Children's Institute for Genomic Medicine, a U.S.-based research institute, reported that a study conducted at Rady Children's Hospital found that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This heightened prevalence of genetic diseases in infants has driven the demand for prenatal testing and newborn screening.

The prenatal testing and newborn screening market is poised for growth due to an increase in birth rates. Prenatal testing assesses the health of fetuses before birth, while newborn screening detects specific medical conditions shortly after birth, enabling early intervention when necessary. For example, in April 2024, a report published by the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, revealed that the cesarean delivery rate increased for the fourth consecutive year in 2023, reaching 32.4%. Additionally, the rate of low-risk cesarean deliveries rose to 26.6%. Therefore, the rising birth rate is a key driver of the prenatal testing and newborn screening market.

Leading companies in the prenatal testing and newborn screening market are focusing on introducing innovative programs that leverage rapid Whole Genome Sequencing (rWGS) technology to quickly and accurately detect genetic disorders in newborns, allowing for early diagnosis and intervention to improve health outcomes. rWGS technology is an advanced genomic technique that rapidly sequences an individual's entire genome. Unlike traditional genetic testing methods that target specific genes or regions, rWGS captures all the DNA in a person's genome to identify genetic variants associated with diseases or disorders. For example, in June 2022, Rady Children's Institute for Genomic Medicine, a U.S.-based organization, launched BeginNGS, a novel program aimed at identifying and diagnosing approximately 400 genetic disorders with known treatment options before symptoms appear. BeginNGS is optimizing genomic sequencing processes and plans to expand testing capabilities to include around 1,000 disorders. The ultimate goal is to screen 3.7 million newborns annually, making this practice a standard procedure in hospitals nationwide.

Key players in the prenatal testing and newborn screening market are focused on developing innovative newborn screening devices to enhance the early detection of genetic, metabolic, and other health conditions, enabling timely interventions and improved health outcomes for newborns. Newborn screening point-of-care devices are designed to provide faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For example, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, priced at about one-fifth of existing solutions, which typically range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

In January 2022, Exact Sciences Corp., a molecular diagnostics company, completed the acquisition of Prevention Genetics for $190 million. This acquisition enhances Exact Sciences' advanced cancer diagnostics portfolio and allows the company to enter the hereditary cancer testing (HCT) market. Prevention Genetics, a company specializing in clinical DNA (genetic) tests for prenatal testing and newborn screening, complements Exact Sciences' capabilities and expands its market presence.

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal testing & newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The prenatal testing & newborn screening market includes revenues earned by entities by providing blood test services, hearing test services, CCHD screening tests, and non-invasive tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal Testing & Newborn Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal testing & newborn screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal testing & newborn screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal testing & newborn screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Type: Non-Invasive; Invasive
  • 2) By Technology: Screening Technology; Diagnostic Technology
  • 3) By End user: Hospitals; Diagnostic centers
  • Subsegments:
  • 1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
  • 2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis
  • Companies Mentioned: PerkinElmer Inc.; Laboratory Corporation of America Holdings (LabCorp); Natera Inc.; Invitae Corporation; Centogene AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal Testing & Newborn Screening Market Characteristics

3. Prenatal Testing & Newborn Screening Market Trends And Strategies

4. Prenatal Testing & Newborn Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Prenatal Testing & Newborn Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Prenatal Testing & Newborn Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Prenatal Testing & Newborn Screening Market Growth Rate Analysis
  • 5.4. Global Prenatal Testing & Newborn Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Prenatal Testing & Newborn Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Prenatal Testing & Newborn Screening Total Addressable Market (TAM)

6. Prenatal Testing & Newborn Screening Market Segmentation

  • 6.1. Global Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive
  • Invasive
  • 6.2. Global Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening Technology
  • Diagnostic Technology
  • 6.3. Global Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic centers
  • 6.4. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Non-Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests (C ell-Free DNA Testing)
  • Ultrasound
  • Maternal Serum Screening
  • 6.5. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amniocentesis
  • Chorionic Villus Sampling (CVS)
  • Cordocentesis

7. Prenatal Testing & Newborn Screening Market Regional And Country Analysis

  • 7.1. Global Prenatal Testing & Newborn Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Prenatal Testing & Newborn Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal Testing & Newborn Screening Market

  • 8.1. Asia-Pacific Prenatal Testing & Newborn Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal Testing & Newborn Screening Market

  • 9.1. China Prenatal Testing & Newborn Screening Market Overview
  • 9.2. China Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal Testing & Newborn Screening Market

  • 10.1. India Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal Testing & Newborn Screening Market

  • 11.1. Japan Prenatal Testing & Newborn Screening Market Overview
  • 11.2. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal Testing & Newborn Screening Market

  • 12.1. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal Testing & Newborn Screening Market

  • 13.1. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal Testing & Newborn Screening Market

  • 14.1. South Korea Prenatal Testing & Newborn Screening Market Overview
  • 14.2. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal Testing & Newborn Screening Market

  • 15.1. Western Europe Prenatal Testing & Newborn Screening Market Overview
  • 15.2. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal Testing & Newborn Screening Market

  • 16.1. UK Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal Testing & Newborn Screening Market

  • 17.1. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal Testing & Newborn Screening Market

  • 18.1. France Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal Testing & Newborn Screening Market

  • 19.1. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal Testing & Newborn Screening Market

  • 20.1. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal Testing & Newborn Screening Market

  • 21.1. Eastern Europe Prenatal Testing & Newborn Screening Market Overview
  • 21.2. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal Testing & Newborn Screening Market

  • 22.1. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal Testing & Newborn Screening Market

  • 23.1. North America Prenatal Testing & Newborn Screening Market Overview
  • 23.2. North America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal Testing & Newborn Screening Market

  • 24.1. USA Prenatal Testing & Newborn Screening Market Overview
  • 24.2. USA Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal Testing & Newborn Screening Market

  • 25.1. Canada Prenatal Testing & Newborn Screening Market Overview
  • 25.2. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal Testing & Newborn Screening Market

  • 26.1. South America Prenatal Testing & Newborn Screening Market Overview
  • 26.2. South America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal Testing & Newborn Screening Market

  • 27.1. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal Testing & Newborn Screening Market

  • 28.1. Middle East Prenatal Testing & Newborn Screening Market Overview
  • 28.2. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal Testing & Newborn Screening Market

  • 29.1. Africa Prenatal Testing & Newborn Screening Market Overview
  • 29.2. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal Testing & Newborn Screening Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal Testing & Newborn Screening Market Competitive Landscape
  • 30.2. Prenatal Testing & Newborn Screening Market Company Profiles
    • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Centogene AG Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal Testing & Newborn Screening Market Other Major And Innovative Companies

  • 31.1. Cradle Genomics Inc.
  • 31.2. Roche Diagnostics International AG
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Baebies Inc.
  • 31.5. Progenity Inc.
  • 31.6. Ravgen Inc.
  • 31.7. Strand Life Sciences Pvt. Ltd.
  • 31.8. Eurofins Scientific
  • 31.9. Illumina Inc.
  • 31.10. Agilent Technologies Inc.
  • 31.11. Thermo Fisher Scientific Inc.
  • 31.12. F. Hoffmann-La Roche Ltd.
  • 31.13. Bio-Rad Laboratories Inc.
  • 31.14. General Electric Company
  • 31.15. Siemens Healthineers AG

32. Global Prenatal Testing & Newborn Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal Testing & Newborn Screening Market

34. Recent Developments In The Prenatal Testing & Newborn Screening Market

35. Prenatal Testing & Newborn Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Prenatal Testing & Newborn Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Prenatal Testing & Newborn Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Prenatal Testing & Newborn Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer